P2RY11 and breast carcinoma: Furthermore, this study, for the first time, revealed the important functional interplay of a purinergic receptor P2Y11 and a chemokine receptor, CXCR4, in mediating the effect of ATP in inhibiting breast cancer bone metastasis.